Showing results (171-180 of 276) with videos related to
Sort By:
Pageof 28
JMIR Cancer|August 9, 2017
Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer PatientsAndreas D Hartkopf, Joachim Graf, Elisabeth Simoes, et al.European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.International Journal of Molecular Sciences|April 13, 2024
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease OutcomeAnna Seller, Christian M Tegeler, Jonas Mauermann, et al.Geburtshilfe Und Frauenheilkunde|June 25, 2021
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus ConferenceMichael Untch, Peter A Fasching, Sara Y Brucker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerWolfgang J Janni, Brigitte Rack, Leon W M M Terstappen, et al.Breast Care (Basel, Switzerland)|August 12, 2022
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus ConferenceCornelia Kolberg-Liedtke, Diana Lüftner, Sara Y Brucker, et al.Scientific Reports|October 1, 2020
DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)Yogesh Singh, Christoph Trautwein, Achal Dhariwal, et al.Breast Cancer Research and Treatment|October 3, 2018
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancerSarah F Jauch, Sabine Riethdorf, Martin R Sprick, et al.Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.Geburtshilfe Und Frauenheilkunde|August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)Michael Untch, Jens Huober, Christian Jackisch, et al.Pageof 28